Stockscreener 앱 받기
46.30
1.76%
-0.83
전일 마감가:
$47.13
열려 있는:
$46.78
하루 거래량:
388.45K
Relative Volume:
0.84
시가총액:
$1.46B
수익:
$566.77M
순이익/손실:
$48.16M
주가수익비율:
38.91
EPS:
1.19
순현금흐름:
$274.29M
1주 성능:
-6.62%
1개월 성능:
-0.81%
6개월 성능:
+56.58%
1년 성능:
+61.61%
1일 변동 폭
$45.80
$47.44
1주일 범위
$45.80
$50.79
52주 변동 폭
$23.23
$50.79
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
명칭
Collegium Pharmaceutical Inc
전화
781-713-3699
주소
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
COLL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
46.30 | 1.49B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
125.82 | 55.71B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.59 | 49.38B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.11 | 44.89B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.21 | 35.96B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
487.25 | 21.36B | 3.08B | 1.24B | 1.07B | 25.61 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-01-10 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-05-10 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-10 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-08-25 | 재확인 | Needham | Buy |
| 2023-05-02 | 재개 | Jefferies | Buy |
| 2022-08-08 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-14 | 개시 | BWS Financial | Sell |
| 2020-05-27 | 개시 | Guggenheim | Neutral |
| 2020-02-19 | 재개 | Jefferies | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-05-03 | 재개 | H.C. Wainwright | Buy |
| 2019-04-12 | 재개 | Janney | Buy |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-01-16 | 재확인 | Needham | Buy |
| 2018-03-08 | 재확인 | H.C. Wainwright | Buy |
| 2018-02-07 | 재확인 | Needham | Buy |
| 2017-12-05 | 재확인 | Needham | Buy |
| 2017-09-11 | 개시 | H.C. Wainwright | Buy |
| 2017-05-11 | 재확인 | Needham | Buy |
| 2016-09-13 | 개시 | Gabelli & Co | Buy |
| 2015-06-01 | 개시 | Jefferies | Buy |
| 2015-06-01 | 개시 | Needham | Buy |
| 2015-06-01 | 개시 | Piper Jaffray | Overweight |
모두보기
Collegium Pharmaceutical Inc 주식(COLL)의 최신 뉴스
Collegium Pharmaceutical (NASDAQ:COLL) Stock Price Down 5%Here's What Happened - MarketBeat
Collegium Announces the Closing of $980 Million Syndicated Credit Facility - The Globe and Mail
Liquidity Mapping Around (COLL) Price Events - Stock Traders Daily
Collegium Pharmaceutical Closes New $980 Million Credit Facility - TipRanks
Collegium Pharmaceutical Closes $980 Million Syndicated Credit Facility - marketscreener.com
Collegium Pharmaceutical Signs Credit Agreement With Truist Bank - TradingView — Track All Markets
Collegium Pharmaceutical, Inc. Announces the Closing of $980 Million Syndicated Credit Facility - marketscreener.com
Pacer Advisors Inc. Sells 87,066 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
2 Reasons to Avoid COLL and 1 Stock to Buy Instead - Yahoo Finance
Collegium Pharmaceutical stock hits all-time high at 49.92 USD By Investing.com - Investing.com Nigeria
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 12-Month HighStill a Buy? - MarketBeat
Collegium Pharmaceutical stock hits all-time high at 49.92 USD - Investing.com India
Is Collegium Pharmaceutical Inc a good long term investmentMarket Rumors and News & High Yield Trading Plans - earlytimes.in
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? - sharewise.com
Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year? - Yahoo Finance
Assenagon Asset Management S.A. Purchases 92,898 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Can Collegium Pharmaceutical Inc. stock sustain free cash flow growthTrade Entry Summary & Daily Profit Maximizing Trade Tips - bolumsonucanavari.com
Will Collegium Pharmaceutical Inc. stock benefit from commodity pricesInsider Buying & Advanced Technical Analysis Signals - Улправда
How rising interest rates impact Collegium Pharmaceutical Inc. stockWeekly Investment Report & Safe Capital Investment Plans - Улправда
Is Strong Q3 Beat And Higher Guidance Altering The Investment Case For Collegium Pharmaceutical (COLL)? - Yahoo Finance
Can Collegium Pharmaceutical Inc. stock beat market expectations this quarterQuarterly Portfolio Summary & Free Weekly Chart Analysis and Trade Guides - Улправда
Understanding the Setup: (COLL) and Scalable Risk - Stock Traders Daily
Published on: 2025-12-19 17:44:17 - DonanımHaber
Is Collegium Pharmaceutical Inc. stock positioned for digital transformationJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - Улправда
3 Unpopular Stocks We Find Risky - Finviz
Will Collegium Pharmaceutical Inc. stock deliver strong dividend growthMarket Volume Report & Comprehensive Market Scan Reports - DonanımHaber
Will Collegium Pharmaceutical Inc. stock benefit from infrastructure spendingJuly 2025 Sentiment & High Conviction Investment Ideas - DonanımHaber
How Collegium Pharmaceutical Inc. stock performs in weak economy - Улправда
Trade Recap: Will Collegium Pharmaceutical Inc. stock benefit from infrastructure spending2025 Support & Resistance & Reliable Intraday Trade Plans - DonanımHaber
Collegium Pharmaceutical Earnings Notes - Trefis
Can Collegium Pharmaceutical Inc. stock outperform in 2025 bull marketJuly 2025 Movers & Long Hold Capital Preservation Tips - Улправда
Best Value Stocks to Buy for Dec. 18 - sharewise.com
Strong Q3 Beat and Guidance Upside Might Change The Case For Investing In Collegium Pharmaceutical (COLL) - simplywall.st
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment? - 富途牛牛
Collegium Pharmaceutical (COLL): Valuation Check After Strong Revenue Beat and Upgraded Full-Year Performance - simplywall.st
Collegium Pharma spikes after 2025 outlook - MSN
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 1-Year HighShould You Buy? - MarketBeat
Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL) - Yahoo Finance
Needham Upgrades Collegium Pharmaceutical (COLL) - MSN
Collegium Pharmaceutical Inc 354 Stock Analysis and ForecastMarket Volatility Update & Exceptional Return Growth - earlytimes.in
Insider Selling: Collegium Pharmaceutical (NASDAQ:COLL) EVP Sells 17,600 Shares of Stock - MarketBeat
Collegium Pharmaceutical stock hits all-time high at 49.11 USD By Investing.com - Investing.com Canada
Collegium Pharmaceutical stock hits all-time high at 49.11 USD - Investing.com
1 Growth Stock Set to Flourishand 2 Facing Challenges - The Globe and Mail
Collegium pharmaceutical EVP Dreyer sells $847k in stock - Investing.com India
Collegium pharmaceutical EVP Dreyer sells $847k in stock By Investing.com - Investing.com Australia
Collegium Pharmaceutical Inc (COLL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
8.30%
0.62%
자본화:
|
볼륨(24시간):